Skip to main content
CartClose Cart
Category

new partnership

Emma Maillard
In Announcement, new partnership, Organoids

Fukushima Medical University, Summit Pharmaceuticals International and CancerTools.org

Fukushima Medical University aims to accelerate cancer research by contributing patient derived organoids to CancerTools.org

London – UK, Fukushima and Tokyo – Japan: CancerTools.org, the research tools arm of Cancer Research UK (CRUK), and the Fukushima Medical University (FMU) and Summit Pharmaceuticals International (SPI) today announced a new partnership to progress their shared mission of accelerating cancer research. Through this partnership, FMU has made their patient derived organoids (F-PDOs) available to the global cancer research tools community.

Progress in cancer research has always been dependent on the generosity and willingness of scientists to make their rare and unique materials accessible to their colleagues. Scientists globally will now be able to access these latest experimental models from FMU for use in disease modelling, drug development, toxicology screening and other related applications.

As part of this partnership, CancerTools.org will work with FMU and their technology transfer partner Summit Pharmaceuticals International (SPI) to bring the production of these organoids in-house and manage quality control and global distribution. These are the first primary tumour tissue – derived organoids to be part of the existing tools portfolio within CancerTools.org.

F-PDOs are well-characterized experimental models derived from patient explants with 15 different types of cancer. Expansion and differentiation of these tissues/cells produces functional “mini-organs”. Preserving similar genetic profile and morphology with source tumour tissue, F-PDOs represent a physiological and patient-specific path to assess safety and efficacy of drugs in addition to disease modelling. Their physiological nature mimics human biology, which allows them to accurately predict patient response to treatment in comparison to traditional systems.

“Our collaboration with CancerTools.org will allow us to achieve our goal of making these incredible technologies accessible to researchers in their pursuit of organoid based research. This is an exciting opportunity for FMU to demonstrate to their scientists how their research efforts can expand beyond the confines of their own lab helping to accelerate cancer research and the associated discoveries worldwide”

Motoki Takagi, Ph.D., of FMU

“At CancerTools.org we are on a mission to accelerate cancer research. Partnering with FMU and SPI allows us to demonstrate to their research community the value of the tools they are developing in their labs. On our end, organoids as experimental models are a complementary addition to the portfolio which will expand the offering and include tools that will benefit in vitro disease modelling, drug discovery and development together with safety and toxicity studies.”

Robert Bondaryk, Global Head, Research Tools, at CRUK

“This is the beginning of an exciting partnership and we look forward to working with CancerTools.org to enable the scientists from FMU effortlessly make a long-standing impact in oncology research by contributing tools to this unique and first of its kind collaborative in this field.”

Katsuya Okuyama, President & CEO of SPI

About CancerTools.org / Cancer Research UK

CancerTools.org, the research tools arm of CRUK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.
Cancer Research UK (CRUK) is the world’s leading charity dedicated to beating cancer through research. It invests more than £400 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.

About Fukushima Medical University

Fukushima Medical University was established for the purpose of educating and fostering medical education of people who contribute to the health, medical care and welfare of people in Fukushima Prefecture. At the same time, as a research institute, it has an important mission of asking the world about the results of constant research.
After the Great East Japan Earthquake and the nuclear power plant accident in 2011, the government quickly supported the resurgence of Fukushima from the perspective of medical care and health, and it has accelerated its activities in cooperation with medical institutions and research institutions around the world. As part of its activities, FMU established the Industry for Medical-Industrial Translational Research in 2012. By bridging the medical community and industry, FMU provides multifaceted support for the development of new drugs, diagnostic reagents and test reagents for cancer-based diseases.
Through these efforts, FMU is contributing to the creation, clustering and employment of pharmaceutical-related industries in Fukushima Prefecture, as well as contributing to the improvement of the quality of cancer treatment and diagnosis within Fukushima Prefecture to maintain and improve the health of the prefectural population.
For more information, visit https://www.fmu.ac.jp/home/trc/en/

About Summit Pharmaceuticals International

SPI is a company that provides support for everything from research and development to manufacturing and sales of pharmaceuticals. They offer cutting edge technology and products from all over the world to the domestic pharmaceutical industry in Japan.
For more information, visit https://www.summitpharma.co.jp/
Emma Maillard
In Announcement, new partnership

Cancer Research UK and CancerTools.org

Cancer Research UK launches CancerTools.org, a not-for-profit, global research tool collaborative

London, UK: Cancer Research UK (CRUK), the world’s largest charitable funder of cancer research, has unveiled a new initiative – CancerTools.org, as its global research tools arm.

CancerTools.org aims to be the premier global non-profit research tools collaborative with a primary focus on supporting cancer research. It is a first of its kind initiative in this space where scientists can contribute research tools developed in their lab, thereby enhancing the impact of their research, supporting fellow scientists in academia and industry.

Research tools include physical, tangible materials such as antibodies, cell lines, organoids, experimental models, etc. that are created in labs around the world, to help researchers materialise the ways in which we understand cancer to ultimately provide patients with the best possible outcomes. Such tools are physically scattered across labs around the world and not easily accessible, so CancerTools.org has been developed to support cancer researchers in accessing and contributing a diverse range of cancer research tools.

“I’m delighted that with the launch of CancerTools.org, we are extending our avenues of support to cancer researchers to further accelerate cancer research breakthroughs through research tools”

Tony Hickson, Chief Business Officer, CRUK

Cancer Research UK has an international footprint and works in partnership with others to advance cancer research and benefits for patients everywhere.

“We’re calling on research institutions and funders around the world to work with CancerTools.org to ensure that cutting edge technologies are shared effectively and efficiently. What’s more, proceeds from the distribution of these tools will be ploughed back into research, helping to further accelerate.”

Iain Foulkes, Executive Director, Research & Innovation CRUK

This new initiative builds on the Ximbio platform created by CRUK 7 year’s ago and aims to create a multi-institution, worldwide collaborative. To date scientists from over 175 institutes have contributed thousands of research tools and benefitted from the 40+ years of knowledge, capability and experience the team has in managing, maintaining, and distributing research tools at a global scale. Through this and various other partnerships, CancerTools.org aims to emphasise its role as the leading non-profit global research tools collaborative in accelerating cancer research.

“Partnering with leading societies, institutes and researchers through a centralised programme - CancerTools.org, will enable cancer researchers globally to collaborate, share knowledge and contribute/acquire research tools, allowing us all to progress our shared Mission. We are creating a direct-to-consumer platform where scientists can contribute their tools easier than ever, enabling them to get on with their research knowing their tools are readily accessible the world over.”

Robert Bondaryk, Global Head, Research Tools

About CancerTools.org

CancerTools.org, the research tools arm of CRUK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.

CancerTools.org is actively seeking cancer research institutes, universities, societies and membership bodies to join the collaborative and enhance the benefits they provide their researchers and members whilst progressing our shared Mission to accelerate cancer research worldwide.

About CRUK

Cancer Research UK (CRUK) is the world’s leading charity dedicated to beating cancer through research. It invests more than £400 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.

Emma Maillard
In Announcement, new partnership

The EACR and CancerTools.org

The EACR and CancerTools.org sign a strategic partnership to accelerate cancer research and drive innovation

London, UK: CancerTools.org, the research tools arm of Cancer Research UK (CRUK), today announced a new partnership with the European Association for Cancer Research (EACR), with a shared mission to accelerate cancer research discoveries. The EACR is the first professional membership organisation to join the global cancer research tools collaborative led by CancerTools.org and CRUK.

The partnership with the EACR is designed to facilitate the success of this collaborative by reaching out to their membership of more than 10,000 cancer researchers to contribute research tools developed in their laboratories, so that other scientists globally can quickly benefit from them in their work. Progress in cancer research has always been dependent on the generosity and willingness of scientists to make their rare and unique materials available to their colleagues to confirm new results in the peer-review process and prevent ‘reinventing the wheel’ to recreate existing resources. CancerTools.org is the first non-profit programme to unite the entire global cancer research community in this important Mission.

As part of this partnership, CancerTools.org will develop a co-marketing collaboration plan with the EACR to benefit its membership to contribute and further develop the existing compendium of research tools. At the same time, the members will be able to access thousands of unique and innovative tools that already have been contributed by researchers from over 175 university partners on six continents at the www.cancertools.org website.

“By partnering with CancerTools.org, we will create new opportunities for our members by promoting the concept of contributing research tools to advance cancer research. This is an exciting opportunity to combine the forces of Cancer Research UK-led CancerTools.org and the EACR to expand the portfolio of research tools and make them quickly and easily accessible to cancer scientists worldwide”

Jane Smith, CEO of the EACR

“Partnering with the prestigious pan-European organization the EACR is a major milestone for CancerTools.org. Together we can work towards our shared mission of accelerating cancer research and drive innovation within this space. As a collaborative, we can reach out to the membership of the EACR and provide them with the only non-profit platform to effortlessly contribute their tools and make an impact in oncology research.”

Robert Bondaryk, Global Head, Research Tools, at CRUK

CancerTools.org offers cancer scientists a resource to contribute their research tools including antibodies, cell lines, organoids, experimental models, etc. and foster collaboration. Through this and various other partnerships, CancerTools.org aims to further reinforce its role as the leading non-profit global research tools collaborative in accelerating cancer research.

About CancerTools.org

CancerTools.org, the research tools arm of CRUK, is a non-profit, global community of cancer researchers, academic institutes and societies, with a shared mission to accelerate cancer research discoveries. In this collaborative, researchers contribute research tools and share knowledge to deepen our understanding of cancer, and drive innovation within cancer research.

About the EACR

The European Association for Cancer Research is a global community of cancer researchers with more than 10,000 members in 100+ countries. Membership is open to anyone working in or studying cancer research and members work across the full spectrum of the field, from basic through to translational and clinical research. The EACR offers collaboration, funding and networking opportunities and organises a full calendar of cancer research conferences.

About CRUK

Cancer Research UK (CRUK) is the world’s leading charity dedicated to beating cancer through research. It invests more than £400 million annually into cancer research through funding schemes, conferences, initiatives, resources, and a UK-wide network of research infrastructure across basic, translational, clinical and population research.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.